93 results on '"Nilotinib -- Research"'
Search Results
2. Findings from Mansoura University Broaden Understanding of Chronic Myeloid Leukemia [The Utility of Insulin Like Growth Factor Binding Proteins (Igfbps-1, 2, 3) With Genes Expression In Resistance To Imatinib and Nilotinib In Chronic Myeloid ...]
3. Recent Findings from University of Nis Highlight Research in Pathophysiology (Low Renalase Levels in Newly Diagnosed CML: Dysregulation Sensitive to Modulation by Tyrosine Kinase Inhibitors)
4. Studies from University of Kansas Medical Center Further Understanding of Tyrosine Kinase Inhibitors (Systematic Approach to Treatment De-Escalation While Maintaining Remission in CML, a Risk Mitigation and Cost Reduction Study)
5. Medical College of Wisconsin Researcher Describes Research in Chronic Myeloid Leukemia [Treatment with Asciminib As a Second Line after One Prior Tyrosine Kinase Inhibitor (TKI) in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) - ...]
6. Hannover Medical School Researcher Yields New Data on Chronic Myeloid Leukemia [Second-Line Bosutinib Is Effective and Feasible in Patients Failing Second Generation TKI (2G-TKI) in Chronic Phase Chronic Myeloid Leukemia (CML) - an Analysis of a ...]
7. Data on Chronic Myeloid Leukemia Published by a Researcher at Tor Vergata University of Rome [Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact Project, a ...]
8. Chiang Mai University Researcher Describes Findings in Vitamin D Deficiency (Vitamin D Deficiency Negatively Affects Responses in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors)
9. Research from University of Utah Reveals New Findings on Chronic Myeloid Leukemia (Disparities in frontline treatment and overall survival in the era of targeted tyrosine kinase inhibitor therapy for chronic myeloid leukemia: 2004-2021)
10. New Chronic Myeloid Leukemia Findings from Pontificia Universidad Catolica de Chile Described (New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive ...)
11. Studies from Hunan University of Science and Engineering Update Current Data on Drugs and Therapies (An Investigation of the Impact of Precipitation Temperature and Filter Cake Thickness on the Physical Stability of Amorphous Solids: A Case ...)
12. Data on Drugs and Therapies Detailed by a Researcher at Hunan University of Science and Engineering (The Optimization of Pair Distribution Functions for the Evaluation of the Degree of Disorder and Physical Stability in Amorphous Solids)
13. New BCR-ABL Tyrosine Kinase Inhibitors Research from Northwestern University Feinberg School of Medicine Discussed (Nilotinib-induced alterations in endothelial cell function recapitulate clinical vascular phenotypes independent of ABL1)
14. Hunan University of Science and Engineering Researcher Illuminates Research in Drugs and Therapies (Investigation of the Influence of Anti-Solvent Precipitation Parameters on the Physical Stability of Amorphous Solids)
15. Affiliated Hospital of North Sichuan Medical College Researchers Discuss Findings in Chronic Myeloid Leukemia (Efficacy and safety of switching to flumatinib in patients with chronic myeloid leukemia who have not achieved optimal response or ...)
16. New Obesity, Fitness and Wellness Data Have Been Reported by Researchers at Hunan University of Science and Engineering (Optimization of Precipitation Conditions for Producing Physically Stable Amorphous Solids Using Pair Distribution Function ...)
17. Research Conducted at University of Medicine and Pharmacy of Craiova Has Provided New Information about Cancer (Quantitative Analysis of Sorafenib and Nilotinib In Human Plasma By Spe-lc-ms)
18. Researcher from Radboud University Medical Center Details New Studies and Findings in the Area of Chronic Myeloid Leukemia (Transporter-Mediated Cellular Distribution of Tyrosine Kinase Inhibitors as a Potential Resistance Mechanism in Chronic ...)
19. Studies from Instituto Nacional de Cancer (INCA) Further Understanding of Chronic Myeloid Leukemia (Bcr-abl Exon 7 Deletion in Chronic Myeloid Leukemia: Challenges in Point Mutations Analysis)
20. Reports Outline Chronic Myeloid Leukemia Study Results from Hospital Universitario Nuestra Senora de Candelaria (Risk factors determining adherence to tyrosine kinase inhibitors in chronic myeloid leukaemia)
21. Reports from Centre Leon Berard Describe Recent Advances in Chronic Myeloid Leukemia (A Multicenter Retrospective Chart Review Study of Treatment and Disease Patterns and Clinical Outcomes of Patients with Chronic-Phase Chronic Myeloid Leukemia ...)
22. Data on Drug Targets Described by Researchers at Deakin University (Explaining Black Box Drug Target Prediction Through Model Agnostic Counterfactual Samples)
23. Studies from Bulgarian Academy of Sciences Provide New Data on Cancer (Ferrocene Modified Analogues of Imatinib and Nilotinib As Potent Anti-cancer Agents)
24. Findings on Obesity, Fitness and Wellness Detailed by Investigators at University of Ioannina (Expressing Enhanced Inhibitory Effects Toward Arachidonic Acid Induced Platelet Activation: Design, Synthesis, Dft Calculations and In Vitro ...)
25. Research from University of Patras School of Medicine Provides New Study Findings on Chronic Myeloid Leukemia (Safety and Tolerability of Nilotinib in Patients with Chronic Myeloid Leukemia during Routine Clinical Practice: Results from the ...)
26. New Chronic Myeloid Leukemia Research from American University of Beirut Outlined (Safety and Efficacy of Elective Switch from Nilotinib to Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia)
27. Research Reports on Chronic Myeloid Leukemia from Kermanshah University of Medical Sciences Provide New Insights (Coexistence of BCR-ABL1 Translocation and JAK2 V617F Mutation in a Patient with Chronic Myeloid Leukemia Under Long-term Treatment ...)
28. Georgetown University Medical Center Researchers Update Knowledge of Huntington Disease (Alteration of Autophagy and Glial Activity in Nilotinib-Treated Huntington's Disease Patients)
29. Kantonsspital Aarau Researchers Update Current Study Findings on Chronic Myeloid Leukemia (A multicenter real-world evidence study in the Swiss treatment landscape of chronic myeloid leukemia)
30. Studies from Fudan University Describe New Findings in Adenocarcinoma (Complement system-related genes in stomach adenocarcinoma: Prognostic signature, immune landscape, and drug resistance)
31. Reports from Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico Add New Study Findings to Research in Chronic Myeloid Leukemia (Case report: Pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: Not ...)
32. Research Study Findings from Faculty of Medicine Universitas Padjadjaran Update Understanding of Leukemia (Global Longitudinal Strain of Chronic Granulocytic Leukemia Patients treated with Imatinib and Nilotinib)
33. New Chronic Myeloid Leukemia Study Results from University of Cincinnati Described (Safety and Cost-effectiveness of Ponatinib Versus Other Tyrosine Kinase Inhibitors As Second-line Therapy In Patients With Chronic Myeloid Leukemia In the ...)
34. Report Summarizes Personalized Medicine Study Findings from Affiliated Hospital of Nantong University (Comprehensive Analysis Revealed the Potential Implications of m6A Regulators in Lung Adenocarcinoma)
35. University of Siena Researchers Detail Findings in Oncology [Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study)]
36. Study Results from Department of Hematology Update Understanding of Chronic Myeloid Leukemia (Second-Generation Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response: A Systematic ...)
37. Research from Harbin Medical University Cancer Hospital Yields New Study Findings on Atrial Fibrillation (Tyrosine Kinase Inhibitors-Induced Arrhythmias: From Molecular Mechanisms, Pharmacokinetics to Therapeutic Strategies)
38. Findings on BCR-ABL Tyrosine Kinase Inhibitors Reported by Investigators at Hokkaido University of Science (Simultaneous Quantification of Bcr-abl and Bruton Tyrosine Kinase Inhibitors In Dried Plasma Spots and Its Application To Clinical ...)
39. Researchers from Copenhagen University Hospital Provide Details of New Studies and Findings in the Area of Oncology (Outstanding Response to Sorafenib in a Patient with Metastatic Gastrointestinal Stromal Tumour)
40. Researchers at Yonsei University Wonju College of Medicine Have Published New Study Findings on Chronic Myeloid Leukemia (Survival impact of adherence to tyrosine kinase inhibitor in chronic myeloid leukemia)
41. Researchers from University of North Carolina Report Recent Findings in Chronic Myeloid Leukemia (Response To Tyrosine Kinase Inhibitors In Real-world Patients With Chronic Myeloid Leukemia)
42. University of Tsukuba Researchers Report on Findings in Chronic Myeloid Leukemia (Vasospastic angina in a chronic myeloid leukemia patient treated with nilotinib)
43. Findings from Miyazaki Prefectural Miyazaki Hospital Provides New Data about Acute Lymphoblastic Leukemia (Serial Evaluation of the Pharmacokinetics of Ponatinib In Patients With Cml and Ph Plus All)
44. University of Catania Researchers Report Recent Findings in Pharmacology (Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts)
45. Studies Conducted at University of Virginia on Apoptosis Recently Reported (Computational Model of Cardiomyocyte Apoptosis Identifies Mechanisms of Tyrosine Kinase Inhibitor-induced Cardiotoxicity)
46. New Protease Inhibitors Study Findings Have Been Reported from Ton Duc Thang University (Computational Investigation of Possible Inhibitors of the Winged-helix Domain of Mus81)
47. Research from Islamic Azad University Reveals New Findings on Nanoparticles (Magnetic polymeric core-shell as a carrier for gradual release in-vitro test drug delivery)
48. Reports from Medical University of Sofia Add New Study Findings to Research in Leukemia [Molecular response in long-term monitoring of patients with chronic myelogenic leukemia (CML) on nilotinib therapy]
49. New Findings Reported from RWTH Aachen University Describe Advances in Acute Lymphoblastic Leukemia (Targeting of Bcr-abl1 and Ire1 Alpha Induces Synthetic Lethality In Philadelphia-positive Acute Lymphoblastic Leukemia)
50. Reports Outline Chronic Myeloid Leukemia Study Findings from University Hospital Center Clermont-Ferrand (Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34- and immature CD34+ cells)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.